The present application provides compounds of Formula (B), or pharmaceutically acceptable salts thereof, wherein D is a residue of a biologically active drug, which underdo hydrolysis under physiological conditions to release the biologically active drug and which are useful in the treatment of disorders that could be beneficially treated with the drug.
[EN] DIASTEREOMERIC LINKING REAGENTS FOR NUCLEOTIDE PROBES<br/>[FR] RÉACTIFS DE LIAISON DIASTÉRÉOMÉRIQUES POUR SONDES NUCLÉOTIDIQUES
申请人:BRENTANO BIOTECHNOLOGY ASS
公开号:WO2021061154A1
公开(公告)日:2021-04-01
A versatile reagent with a non-nucleotide monomeric unit comprising an enantiomeric center and having a ligand, and first and second coupling groups that are linked to the non-nucleotide monomeric unit. Such a reagent permits preparation of versatile nucleotide/non-nucleotide polymers, having any desired sequence of nucleotide and non-nucleotide monomeric units, each of the latter of which bear a desired ligand. These polymers can, for example, be used as probes which can exhibit enhanced sensitivity and/or which are capable of detecting a genus of nucleotides each species of which has a common target nucleotide sequence of interest bridged by different sequences not of interest.
Method for solution phase synthesis of oligonucleotides
申请人:Proligo LLC
公开号:US20040116685A1
公开(公告)日:2004-06-17
This invention discloses an improved method for the sequential solution phase synthesis of oligonucleotides. The method lends itself to automation and is ideally suited for large scale manufacture of oligonucleotides with high efficiency.
Recombinant DNA techniques for the production of relaxin
申请人:G.D. Searle & Co.
公开号:EP0068375A2
公开(公告)日:1983-01-05
Synthetic genes for relaxin, the expression thereof, corresponding plasmid recombinants and transformed cells and the production thereof are disclosed.
Relaxin has an application in controlling labour in pregnancy.
公开了松弛素的合成基因、其表达、相应的质粒重组体和转化细胞及其生产。
松弛素可用于控制妊娠分娩。
DNA-Sequenzen, deren Herstellung, diese Sequenzen enthaltende Plasmide und deren Verwendung zur Synthese eukaryotischer Genprodukte in Prokaryoten
申请人:BOEHRINGER INGELHEIM INTERNATIONAL GmbH
公开号:EP0115613A2
公开(公告)日:1984-08-15
Gegenstand der vorliegenden Erfindung ist die Kombination der Promotor/Operator-Region des Tryptophanoperons von Serratia marcescens mit einer synthetischen Ribosomenbindungssequenz, ein diese Sequenz enthaltendes Expressionsplasmid. in welchem anschließend an die obige Sequenz die einzige Hin dIII-Spaltstelle des Plasmids liegt, in die das zur Expression zu bringende Gen eingefügt werden kann, sowie Produktionsplasmide zur Expression eukaryotischer Genprodukte in Prokaryoten, insbesondere zur Herstellung von Leukocyteninterferon.
本发明的目的是将 Serratia marcescens 色氨酸操作子的启动子/操作子区与合成的核糖体结合序列、含有该序列的表达质粒(质粒中唯一的 Hin dIII 分裂位点位于上述序列的下游)以及用于在原核生物中表达真核基因产物的生产质粒(尤其是用于生产白细胞干扰素)结合起来。